• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算机模拟发现抗新冠病毒候选药物

In Silico Discovery of Candidate Drugs against Covid-19.

机构信息

Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Via F.Cervi 93, 20090 Segrate-Milan, Milan, Italy.

Department of Physics "Giuseppe Occhialini", University of Milan-Bicocca Piazza dell'Ateneo Nuovo, 1 - 20126, Milan, Italy.

出版信息

Viruses. 2020 Apr 6;12(4):404. doi: 10.3390/v12040404.

DOI:10.3390/v12040404
PMID:32268515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7232366/
Abstract

Previous studies reported that Angiotensin converting enzyme 2 (ACE2) is the main cell receptor of SARS-CoV and SARS-CoV-2. It plays a key role in the access of the virus into the cell to produce the final infection. In the present study we investigated in silico the basic mechanism of in the lung and provided evidences for new potentially effective drugs for Covid-19. Specifically, we used the gene expression profiles from public datasets including The Cancer Genome Atlas, Gene Expression Omnibus and Genotype-Tissue Expression, Gene Ontology and pathway enrichment analysis to investigate the main functions of -correlated genes. We constructed a protein-protein interaction network containing the genes co-expressed with . Finally, we focused on the genes in the network that are already associated with known drugs and evaluated their role for a potential treatment of Covid-19. Our results demonstrate that the genes correlated with are mainly enriched in the sterol biosynthetic process, Aryldialkylphosphatase activity, adenosylhomocysteinase activity, trialkylsulfonium hydrolase activity, acetate-CoA and CoA ligase activity. We identified a network of 193 genes, 222 interactions and 36 potential drugs that could have a crucial role. Among possible interesting drugs for Covid-19 treatment, we found Nimesulide, Fluticasone Propionate, Thiabendazole, Photofrin, Didanosine and Flutamide.

摘要

先前的研究报告指出,血管紧张素转换酶 2(ACE2)是 SARS-CoV 和 SARS-CoV-2 的主要细胞受体。它在病毒进入细胞产生最终感染中起着关键作用。在本研究中,我们通过计算机模拟研究了肺中的基本机制,并为新冠病毒提供了新的潜在有效药物的证据。具体来说,我们使用了来自公共数据集的基因表达谱,包括癌症基因组图谱、基因表达综合数据库和基因-组织表达数据库、基因本体论和途径富集分析,以研究与 -相关基因的主要功能。我们构建了一个包含与共表达的基因的蛋白质-蛋白质相互作用网络。最后,我们专注于网络中已经与已知药物相关的基因,并评估它们在新冠病毒治疗中的潜在作用。我们的研究结果表明,与相关的基因主要富集在固醇生物合成过程、芳基二烷基磷酸酶活性、腺苷同型半胱氨酸酶活性、三烷基磺基氢酶活性、乙酸-CoA 和 CoA 连接酶活性中。我们确定了一个由 193 个基因、222 个相互作用和 36 种潜在药物组成的网络,这些药物可能具有关键作用。在治疗新冠病毒的可能的有趣药物中,我们发现了尼美舒利、丙酸氟替卡松、噻苯达唑、Photofrin、地昔洛韦和氟他胺。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2660/7232366/b9b08031e221/viruses-12-00404-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2660/7232366/c9441729a24a/viruses-12-00404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2660/7232366/ae793123cf37/viruses-12-00404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2660/7232366/f0c1f875c155/viruses-12-00404-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2660/7232366/b9b08031e221/viruses-12-00404-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2660/7232366/c9441729a24a/viruses-12-00404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2660/7232366/ae793123cf37/viruses-12-00404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2660/7232366/f0c1f875c155/viruses-12-00404-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2660/7232366/b9b08031e221/viruses-12-00404-g004.jpg

相似文献

1
In Silico Discovery of Candidate Drugs against Covid-19.计算机模拟发现抗新冠病毒候选药物
Viruses. 2020 Apr 6;12(4):404. doi: 10.3390/v12040404.
2
Could a specific ACE2 activator drug improve the clinical outcome of SARS-CoV-2? A potential pharmacological insight.一种特定的血管紧张素转换酶2(ACE2)激活剂药物能否改善2019冠状病毒病(SARS-CoV-2)的临床结局?一项潜在的药理学见解。
Expert Rev Clin Pharmacol. 2020 Aug;13(8):807-811. doi: 10.1080/17512433.2020.1798760. Epub 2020 Jul 25.
3
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
4
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.血管紧张素转换酶 2 的器官保护作用及其对 COVID-19 预后的影响。
J Med Virol. 2020 Jul;92(7):726-730. doi: 10.1002/jmv.25785. Epub 2020 Apr 5.
5
A protein interaction map identifies existing drugs targeting SARS-CoV-2.蛋白质相互作用图谱鉴定出针对 SARS-CoV-2 的现有药物。
BMC Pharmacol Toxicol. 2020 Sep 3;21(1):65. doi: 10.1186/s40360-020-00444-z.
6
Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.新冠病毒 2 型受体(SARS-CoV-2 receptor),血管紧张素转换酶 2 基因(angiotensin-converting enzyme 2 gene)在 COVID-19 中的表达和意义。
Mol Biol Rep. 2020 Jun;47(6):4383-4392. doi: 10.1007/s11033-020-05478-4. Epub 2020 May 14.
7
In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.基于分子对接的针对 SARS-CoV-2 3CLpro 和血管紧张素转化酶 II 的新冠病毒潜在中草药的计算机筛选
Chin J Integr Med. 2020 Jul;26(7):527-532. doi: 10.1007/s11655-020-3476-x. Epub 2020 Jul 6.
8
The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.SARS-CoV-2 利用血管紧张素转换酶 2 进入细胞进行复制的机制概述:与肾素-血管紧张素系统相关的可能治疗选择。
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):317-325. doi: 10.1093/ehjcvp/pvaa053.
9
ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV.ACE2 和 ACE:基于结构的 SARS-CoV 机制、调控和受体识别的见解。
Clin Sci (Lond). 2020 Nov 13;134(21):2851-2871. doi: 10.1042/CS20200899.
10
ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery.ACE2,肾脏与 ACE2 发现二十年后的 COVID-19 。
Clin Sci (Lond). 2020 Nov 13;134(21):2791-2805. doi: 10.1042/CS20200484.

引用本文的文献

1
Expression of MCCC2 in glioma cells and preliminary verification of poor prognosis.MCCC2在胶质瘤细胞中的表达及预后不良的初步验证。
Biomark Med. 2025 Mar;19(6):205-213. doi: 10.1080/17520363.2025.2473131. Epub 2025 Mar 4.
2
Adopting Integrated Bioinformatics and Systems Biology Approaches to Pinpoint the COVID-19 Patients' Risk Factors That Uplift the Onset of Posttraumatic Stress Disorder.采用综合生物信息学和系统生物学方法来确定导致COVID-19患者发生创伤后应激障碍的风险因素。
Bioinform Biol Insights. 2024 Sep 11;18:11779322241274958. doi: 10.1177/11779322241274958. eCollection 2024.
3
Rational Approach toward COVID-19's Main Protease Inhibitors: A Hierarchical Biochemoinformatics Analysis.

本文引用的文献

1
Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation.SARS-CoV-2 受体 ACE2 基因表达和调控的个体差异。
Aging Cell. 2020 Jul;19(7). doi: 10.1111/acel.13168. Epub 2020 Jun 19.
2
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.基于网络的2019新型冠状病毒(2019-nCoV/SARS-CoV-2)药物重新利用研究
Cell Discov. 2020 Mar 16;6:14. doi: 10.1038/s41421-020-0153-3. eCollection 2020.
3
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.
理性看待 COVID-19 的主要蛋白酶抑制剂:层次化的生物化学信息学分析。
Int J Mol Sci. 2024 Jun 18;25(12):6715. doi: 10.3390/ijms25126715.
4
Molecular modeling of some commercially available antiviral drugs and their derivatives against SARS-CoV-2 infection.针对 SARS-CoV-2 感染的一些市售抗病毒药物及其衍生物的分子建模。
Narra J. 2024 Apr;4(1):e319. doi: 10.52225/narra.v4i1.319. Epub 2024 Apr 30.
5
Analysis of Plasma Proteins Involved in Inflammation, Immune Response/Complement System, and Blood Coagulation upon Admission of COVID-19 Patients to Hospital May Help to Predict the Prognosis of the Disease.分析 COVID-19 患者入院时涉及炎症、免疫反应/补体系统和凝血的血浆蛋白,可能有助于预测疾病的预后。
Cells. 2023 Jun 10;12(12):1601. doi: 10.3390/cells12121601.
6
Integrating Computational Methods in Network Pharmacology and Screening to Uncover Multi-targeting Phytochemicals against Aberrant Protein Glycosylation in Lung Cancer.整合网络药理学中的计算方法并进行筛选,以发现针对肺癌中异常蛋白糖基化的多靶点植物化学物质。
ACS Omega. 2023 May 30;8(23):20303-20312. doi: 10.1021/acsomega.2c07542. eCollection 2023 Jun 13.
7
Outpatient medications associated with protection from COVID-19 hospitalization.与预防 COVID-19 住院相关的门诊药物。
PLoS One. 2023 Mar 31;18(3):e0282961. doi: 10.1371/journal.pone.0282961. eCollection 2023.
8
Integrative Investigation Reveals the Host-Virus Interactions in Repurposed Drugs Against SARS-CoV-2.综合研究揭示了老药抗新型冠状病毒的宿主-病毒相互作用。
Front Bioinform. 2022 Jan 11;1:763540. doi: 10.3389/fbinf.2021.763540. eCollection 2021.
9
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies.用于治疗新冠肺炎的新型药物设计:临床前研究的系统综述
Can J Infect Dis Med Microbiol. 2022 Sep 25;2022:2044282. doi: 10.1155/2022/2044282. eCollection 2022.
10
A Review of In Silico Research, SARS-CoV-2, and Neurodegeneration: Focus on Papain-Like Protease.计算机模拟研究、SARS-CoV-2 与神经退行性变综述:聚焦木瓜蛋白酶样蛋白酶
Neurotox Res. 2022 Oct;40(5):1553-1569. doi: 10.1007/s12640-022-00542-2. Epub 2022 Aug 2.
将临床批准的药物重新用于治疗 2019 年新型冠状病毒相关冠状病毒模型中的 2019 年冠状病毒病。
Chin Med J (Engl). 2020 May 5;133(9):1051-1056. doi: 10.1097/CM9.0000000000000797.
4
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
5
Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.新型冠状病毒肺炎(COVID-19)具有独特的流行病学和临床特征,提示应采取特殊的控制措施。
J Med Virol. 2020 Jun;92(6):568-576. doi: 10.1002/jmv.25748. Epub 2020 Mar 29.
6
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential.广谱抗病毒药物氯硝柳胺及其治疗潜力。
ACS Infect Dis. 2020 May 8;6(5):909-915. doi: 10.1021/acsinfecdis.0c00052. Epub 2020 Mar 10.
7
[Epidemic trend of COVID-19 in Chinese mainland].[中国大陆新型冠状病毒肺炎疫情趋势]
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Jun 6;54(6):620-624. doi: 10.3760/cma.j.cn112150-20200222-00163.
8
[Dynamic basic reproduction number based evaluation for current prevention and control of COVID-19 outbreak in China].基于动态基本再生数对中国当前新冠疫情防控的评估
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Apr 10;41(4):466-469. doi: 10.3760/cma.j.cn112338-20200209-00080.
9
Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection.胰蛋白酶处理解锁了人畜共患蝙蝠冠状病毒感染的屏障。
J Virol. 2020 Feb 14;94(5). doi: 10.1128/JVI.01774-19.
10
Membrane Cholesterol Modulates Oligomeric Status and Peptide-Membrane Interaction of Severe Acute Respiratory Syndrome Coronavirus Fusion Peptide.膜胆固醇调节严重急性呼吸综合征冠状病毒融合肽的寡聚状态和肽-膜相互作用。
J Phys Chem B. 2019 Dec 19;123(50):10654-10662. doi: 10.1021/acs.jpcb.9b08455. Epub 2019 Dec 6.